Yifan Pharmaceutical Management
Management criteria checks 4/4
Yifan Pharmaceutical's CEO is Xian Feng Cheng, appointed in Nov 2017, has a tenure of 7.17 years. directly owns 40.82% of the company’s shares, worth CN¥5.16B. The average tenure of the management team and the board of directors is 2.7 years and 9.5 years respectively.
Key information
Xian Feng Cheng
Chief executive officer
CN¥624.0k
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | 7.2yrs |
| CEO ownership | 40.8% |
| Management average tenure | 2.7yrs |
| Board average tenure | 9.5yrs |
Recent management updates
Recent updates
CEO
Xian Feng Cheng (56 yo)
7.2yrs
Tenure
CN¥624,000
Compensation
Mr. Xian feng Cheng serves as the Chairman of the Board of Directors at Yifan Pharmaceutical Co., Ltd and serves as its Director since October 15, 2014 and serves as its General Manager since November 07,...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Chairman of the Board of Directors & GM | 7.2yrs | CN¥624.00k | 40.82% CN¥ 5.2b | |
| Financial Director | 1.5yrs | CN¥240.00k | 0.0032% CN¥ 401.0k | |
| Deputy GM & Director | 12.2yrs | CN¥564.00k | 0.063% CN¥ 8.0m | |
| Board Secretary | no data | CN¥480.00k | 0.060% CN¥ 7.6m | |
| Deputy General Manager | 2.7yrs | CN¥2.74m | 0.0020% CN¥ 254.3k | |
| Deputy General Manager | 2.7yrs | CN¥1.87m | 0.0032% CN¥ 406.1k | |
| Head of Accounting | no data | no data | no data | |
| Director of Sales Team | no data | no data | no data |
2.7yrs
Average Tenure
49yo
Average Age
Experienced Management: 002019's management team is considered experienced (2.7 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Chairman of the Board of Directors & GM | 10.3yrs | CN¥624.00k | 40.82% CN¥ 5.2b | |
| Deputy GM & Director | 12.2yrs | CN¥564.00k | 0.063% CN¥ 8.0m | |
| Board Secretary | 8.8yrs | CN¥480.00k | 0.060% CN¥ 7.6m | |
| Supervisor | 6.8yrs | no data | 0.000010% CN¥ 1.3k | |
| Member of the Supervisory Board | 10.3yrs | CN¥234.20k | no data | |
| Director | 10.3yrs | CN¥480.00k | 0.058% CN¥ 7.4m | |
| Director | 10.3yrs | CN¥480.00k | 0.032% CN¥ 4.1m | |
| Independent Director | 4.2yrs | CN¥100.00k | no data | |
| Independent Director | 5.8yrs | CN¥100.00k | no data | |
| Independent Director | 5.8yrs | CN¥100.00k | no data |
9.5yrs
Average Tenure
51.5yo
Average Age
Experienced Board: 002019's board of directors are considered experienced (9.5 years average tenure).
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/01/09 23:19 |
| End of Day Share Price | 2025/01/09 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Yifan Pharmaceutical Co., Ltd. is covered by 8 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Shitong Han | Citic Securities Co., Ltd. |
| Xiao Wei Lin | Everbright Securities Co. Ltd. |
| Zhenghua Zhang | Founder Securities Co., Ltd. |